223 related articles for article (PubMed ID: 16922702)
1. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
[TBL] [Abstract][Full Text] [Related]
3. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
[TBL] [Abstract][Full Text] [Related]
4. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
Berndt J; Klöting N; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Diabetes; 2005 Oct; 54(10):2911-6. PubMed ID: 16186392
[TBL] [Abstract][Full Text] [Related]
5. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
6. Correlation between polymorphisms in the visfatin gene and its expression in the serum and coronary artery calcification.
Jin LW; Zheng SB; Zhou ZH; Pan SF; Zheng Y
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421003
[TBL] [Abstract][Full Text] [Related]
7. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
[TBL] [Abstract][Full Text] [Related]
8. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.
Sandeep S; Velmurugan K; Deepa R; Mohan V
Metabolism; 2007 Apr; 56(4):565-70. PubMed ID: 17379018
[TBL] [Abstract][Full Text] [Related]
9. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.
Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W
Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330
[TBL] [Abstract][Full Text] [Related]
10. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
[TBL] [Abstract][Full Text] [Related]
11. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin levels, adiposity and glucose metabolism in obese adolescents.
Taşkesen D; Kirel B; Us T
J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):76-81. PubMed ID: 22672864
[TBL] [Abstract][Full Text] [Related]
13. Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders.
Kamińska A; Kopczyńska E; Bieliński M; Borkowska A; Junik R
Endokrynol Pol; 2015; 66(2):108-13. PubMed ID: 25931039
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population.
Stastny J; Bienertova-Vasku J; Tomandl J; Tomandlova M; Zlamal F; Forejt M; Splichal Z; Vasku A
Diabetes Metab Syndr; 2013; 7(3):166-71. PubMed ID: 23953183
[TBL] [Abstract][Full Text] [Related]
15. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
[TBL] [Abstract][Full Text] [Related]
16. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
[TBL] [Abstract][Full Text] [Related]
17. Association of type 2 diabetes mellitus with the interaction between low-density lipoprotein receptor-related protein 5 (LRP5) polymorphisms and overweight and obesity in rural Chinese adults.
Zhang L; Wang J; Zhang M; Wang G; Shen Y; Wu D; Wang C; Li L; Ren Y; Wang B; Zhang H; Yang X; Zhao Y; Han C; Zhou J; Pang C; Yin L; Zhao J; Luo X; Hu D
J Diabetes; 2017 Nov; 9(11):994-1002. PubMed ID: 28067456
[TBL] [Abstract][Full Text] [Related]
18. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
19. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
[TBL] [Abstract][Full Text] [Related]
20. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
